The synergistic anticandidal activity of three diketopiperazines [cyclo-(L-Pro-L-Leu) (1), cyclo-(D-Pro-L-Leu) (2), and cyclo-(D-Pro-L-Tyr) (3)] purified from a Bacillus sp. N strain associated with entomopathogenic nematode Rhabditis (Oscheius) in combination with amphotericin B and clotrimazole was investigated using the macrodilution method. The minimum inhibitory concentration and minimum fungicidal concentration of the diketopiperazines was compared with that of the standard antibiotics. The synergistic anticandidal activities of diketopiperazines with amphotericin B or clotrimazole were assessed using the checkerboard and time-kill methods. The results of the present study showed that the combined effects of diketopiperazines with amphotericin B or clotrimazole predominantly recorded synergistic (<0.5). Time-kill study showed that the growth of the Candida was completely attenuated after 12-24 h of treatment with 50:50 ratios of diketopiperazines and antibiotics. These results suggest that diketopiperazines combined with antibiotics may be microbiologically beneficial and not antagonistic. These findings have potential implications in delaying the development of resistance as the anticandidal effect is achieved with lower concentrations of both drugs (diketopiperazines and antibiotics). The cytotoxicity of diketopiperazines was also tested against two normal human cell lines (L231 lung epithelial and FS normal fibroblast) and no cytotoxicity was recorded for diketopiperazines up to 200 μg/mL. The in vitro synergistic activity of diketopiperazines with antibiotics against Candida albicans is reported here for the first time.

Division of Crop Protection Division of Crop Utilization Central Tuber Crops Research Institute Sreekariyam Thiruvananthapuram 695017 India

Zobrazit více v PubMed

J Appl Oral Sci. 2008 Mar-Apr;16(2):86-94 PubMed

Clin Microbiol Rev. 1999 Oct;12(4):501-17 PubMed

Antimicrob Agents Chemother. 2003 Jul;47(7):2113-7 PubMed

Clin Infect Dis. 2003 May 15;36(10):1221-8 PubMed

J Infect Dis. 2006 May 15;193(10):1408-18 PubMed

Antimicrob Agents Chemother. 2005 Sep;49(9):3640-5 PubMed

Am J Public Health. 1993 Dec;83(12):1739-42 PubMed

Pharmacotherapy. 2001 Aug;21(8 Pt 2):149S-164S PubMed

Antimicrob Agents Chemother. 1998 May;42(5):1207-12 PubMed

Antimicrob Agents Chemother. 2004 Mar;48(3):693-715 PubMed

N Engl J Med. 1992 Mar 26;326(13):845-51 PubMed

Bioorg Med Chem Lett. 2007 Jul 1;17(13):3686-9 PubMed

Clin Microbiol Rev. 1997 Apr;10(2):277-97 PubMed

Int J Antimicrob Agents. 2004 Nov;24(5):423-7 PubMed

Am J Med. 1993 Jun;94(6):577-82 PubMed

Antimicrob Agents Chemother. 1987 Dec;31(12):1874-8 PubMed

Curr Opin Pulm Med. 1999 Nov;5(6):371-7 PubMed

Curr Microbiol. 2002 Oct;45(4):250-4 PubMed

Appl Environ Microbiol. 2004 Dec;70(12):7466-73 PubMed

Proc Natl Acad Sci U S A. 2003 Jun 24;100(13):7977-82 PubMed

J Pharm Pharmacol. 2004 Sep;56(9):1143-53 PubMed

Appl Environ Microbiol. 2002 Sep;68(9):4322-7 PubMed

J Gen Appl Microbiol. 2002 Dec;48(6):321-7 PubMed

Clin Infect Dis. 1999 Aug;29(2):239-44 PubMed

Science. 2005 Sep 30;309(5744):2175-6 PubMed

Science. 2005 Sep 30;309(5744):2185-9 PubMed

J Antimicrob Chemother. 2002 Dec;50(6):999-1002 PubMed

Am J Med. 1991 Sep 16;91(3B):86S-89S PubMed

Antimicrob Agents Chemother. 1995 Jan;39(1):1-8 PubMed

Peptides. 1995;16(1):151-64 PubMed

Appl Environ Microbiol. 2004 Dec;70(12):7311-20 PubMed

Biomol Eng. 2003 Jul;20(4-6):311-6 PubMed

J Biol Chem. 2003 Jul 11;278(28):25490-8 PubMed

J Antimicrob Chemother. 2003 Jun;51(6):1427-9 PubMed

J Control Release. 2003 Feb 21;87(1-3):23-32 PubMed

Microbiol Rev. 1996 Mar;60(1):21-43 PubMed

J Appl Microbiol. 2012 Oct;113(4):914-24 PubMed

Clin Infect Dis. 1999 Aug;29(2):253-8 PubMed